Literature DB >> 9701457

Atherosclerosis: coagulation and fibrinolysis.

K Sueishi1, K Ichikawa, K Kato, K Nakagawa, Y X Chen.   

Abstract

Tissue factor (TF) protein was overexpressed by macrophages and smooth muscle cells (SMCs) and deposited in the extracellular matrix of atherosclerotic intimas, probably resulting in enhanced procoagulant activity and the intimate participation in either thrombus formation or intimal fibrin deposition after the exposure of flowing blood and permeated fibrinogen to TF in atherosclerotic lesions. On the other hand, APO(a) was localized both in the stroma and within some macrophages. Fibrin deposition, which was more frequently detected in the matrix of advanced lesions than in that of early lesions, occasionally colocated with cell- and matrix-associated TF and APO(a) deposited in the matrix. These findings further support the hypothesis that the coagulation and fibrinolysis systems can play an essential role in the initiation and progression of atherosclerosis through fibrin deposition both in atherosclerotic plaques and on the arterial surface by neointimal hypercoagulability and a hypofibrinolytic state, which can also participate in SMC proliferation due to the decreased activation of TGF-beta by embedded and deposited APO(a). The clinical implications of these phenomena may thus contribute to future investigations in the prevention and treatment of atherosclerotic diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701457     DOI: 10.1055/s-2007-995851

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  9 in total

1.  The procoagulant potential of environmental particles (PM10).

Authors:  P S Gilmour; E R Morrison; M A Vickers; I Ford; C A Ludlam; M Greaves; K Donaldson; W MacNee
Journal:  Occup Environ Med       Date:  2005-03       Impact factor: 4.402

2.  Fibulin-1 and fibrinogen in human atherosclerotic lesions.

Authors:  W Scott Argraves; Asashi Tanaka; Elizabeth P Smith; Waleed O Twal; Kelley M Argraves; Daping Fan; Christian C Haudenschild
Journal:  Histochem Cell Biol       Date:  2009-08-20       Impact factor: 4.304

Review 3.  Systemic antiphospholipid syndrome and atherosclerosis.

Authors:  Luis J Jara; Gabriela Medina; Olga Vera-Lastra
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

4.  Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis.

Authors:  Karim Zouaoui Boudjeltia; Jalil Daher; Pierre Van Antwerpen; Nicole Moguilevsky; Paul Delree; Jean Ducobu; Martine Raes; Bassam Badran; Michel Vanhaeverbeek; Dany Brohee; Claude Remacle; Luc Vanhamme
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

5.  Inflammation and oxidative stress markers in diabetes and hypertension.

Authors:  Chloé Pouvreau; Antoine Dayre; Eugene G Butkowski; Beverlie de Jong; Herbert F Jelinek
Journal:  J Inflamm Res       Date:  2018-02-19

6.  Effect of myeloperoxidase modified LDL on bovine and human aortic endothelial cells.

Authors:  Ghadir El Samad; Samer Bazzi; Marc Karam; Karim Zouaoui Boudjeltia; Luc Vanhamme; Jalil Daher
Journal:  Exp Ther Med       Date:  2019-10-17       Impact factor: 2.447

7.  Arsenite Inhibits Tissue-Type Plasminogen Activator Synthesis through NRF2 Activation in Cultured Human Vascular Endothelial EA.hy926 Cells.

Authors:  Tsuyoshi Nakano; Tsutomu Takahashi; Chika Yamamoto; Eiko Yoshida; Toshiyuki Kaji; Yasuyuki Fujiwara
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

Review 8.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

Review 9.  Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation.

Authors:  Sabina Ugovšek; Miran Šebeštjen
Journal:  Biomolecules       Date:  2021-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.